A 22-year-old male presents to the emergency department with a 2-day history of fever (39.5°C), severe headache, neck stiffness, and photophobia. On examination, he has a positive Kernig's sign and Brudzinski's sign. A petechial rash is noted on the trunk and lower extremities. CSF analysis shows: WBC 1200/μL (90% neutrophils), protein 180 mg/dL, glucose 25 mg/dL (serum glucose 95 mg/dL), and Gram stain reveals Gram-negative diplococci. Blood cultures are pending. Which of the following is the most appropriate immediate empirical antibiotic therapy?

Explanation

## Clinical Diagnosis **Key Point:** The clinical presentation (fever, headache, neck stiffness, Kernig's and Brudzinski's signs, petechial rash) is pathognomonic for bacterial meningitis, most likely caused by *Neisseria meningitidis* (meningococcus). ## CSF Findings Supporting Meningococcal Meningitis | Parameter | Finding | Interpretation | |-----------|---------|----------------| | WBC count | 1200/μL (90% neutrophils) | Acute bacterial meningitis | | Protein | 180 mg/dL | Markedly elevated (normal <45) | | Glucose | 25 mg/dL (CSF:serum ratio 0.26) | Severely low; ratio <0.4 suggests bacterial cause | | Gram stain | Gram-negative diplococci | Consistent with *N. meningitidis* | ## Antibiotic Selection **High-Yield:** Empirical therapy for meningitis must cover: 1. *N. meningitidis* (Gram-negative diplococcus) 2. *Streptococcus pneumoniae* (increasingly penicillin-resistant) 3. *Listeria monocytogenes* (in neonates, elderly, immunocompromised) **Clinical Pearl:** Ceftriaxone or cefotaxime penetrate the blood–brain barrier excellently and cover both meningococcus and most penicillin-resistant pneumococci. Vancomycin is added because some pneumococci are cephalosporin-resistant and vancomycin provides synergy. **Mnemonic:** **CVMR** — Ceftriaxone + Vancomycin + Meningitis + Resistant organisms. ## Why Option 0 Is Correct - **Ceftriaxone** (3rd-generation cephalosporin): excellent CSF penetration, covers *N. meningitidis*, *S. pneumoniae*, and Gram-negative rods. - **Vancomycin**: covers penicillin- and cephalosporin-resistant *S. pneumoniae*; synergistic with cephalosporins. - This is the **standard of care** for community-acquired bacterial meningitis in India and worldwide [cite:Harrison 21e Ch 381]. ## Why Other Options Are Suboptimal - **Penicillin G alone:** Does not cover penicillin-resistant *S. pneumoniae*; inadequate monotherapy in the era of resistance. - **Chloramphenicol:** Outdated; poor CSF penetration compared to cephalosporins; no longer recommended. - **Ciprofloxacin:** Fluoroquinolone coverage is inadequate for *S. pneumoniae*; not first-line for meningitis. **Warning:** Delaying vancomycin in suspected meningitis increases mortality. Do not wait for culture confirmation.